Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates.
Meletiadis J, Paranos P, Georgiou PC, Vourli S, Antonopoulou S, Michelaki A, Vagiakou E, Pournaras S. Meletiadis J, et al. Among authors: vourli s. Int J Antimicrob Agents. 2021 Nov;58(5):106440. doi: 10.1016/j.ijantimicag.2021.106440. Epub 2021 Sep 20. Int J Antimicrob Agents. 2021. PMID: 34551356
Emergence and persistent spread of carbapenemase-producing Klebsiella pneumoniae high-risk clones in Greek hospitals, 2013 to 2022.
Tryfinopoulou K, Linkevicius M, Pappa O, Alm E, Karadimas K, Svartström O, Polemis M, Mellou K, Maragkos A, Brolund A, Fröding I, David S, Vatopoulos A, Palm D, Monnet DL, Zaoutis T, Kohlenberg A; Greek CCRE study group; Members of the Greek CCRE study group. Tryfinopoulou K, et al. Euro Surveill. 2023 Nov;28(47):2300571. doi: 10.2807/1560-7917.ES.2023.28.47.2300571. Euro Surveill. 2023. PMID: 37997662 Free PMC article.
An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.
Souli M, Galani I, Antoniadou A, Papadomichelakis E, Poulakou G, Panagea T, Vourli S, Zerva L, Armaganidis A, Kanellakopoulou K, Giamarellou H. Souli M, et al. Among authors: vourli s. Clin Infect Dis. 2010 Feb 1;50(3):364-73. doi: 10.1086/649865. Clin Infect Dis. 2010. PMID: 20041768
Activity of vancomycin, linezolid, and daptomycin against staphylococci and enterococci isolated in 5 Greek hospitals during a 5-year period (2008-2012).
Papadimitriou-Olivgeris M, Kolonitsiou F, Zerva L, Lebessi E, Koutsia C, Drougka E, Sarrou S, Giormezis N, Vourli S, Doudoulakakis A, Konsolakis C, Marangos M, Anastassiou ED, Petinaki E, Spiliopoulou I. Papadimitriou-Olivgeris M, et al. Among authors: vourli s. Diagn Microbiol Infect Dis. 2015 Dec;83(4):386-8. doi: 10.1016/j.diagmicrobio.2015.08.002. Epub 2015 Aug 5. Diagn Microbiol Infect Dis. 2015. PMID: 26341703
Molecular characterization of Streptococcus agalactiae from vaginal colonization and neonatal infections: a 4-year multicenter study in Greece.
Liakopoulos A, Mavroidi A, Vourli S, Panopoulou M, Zachariadou L, Chatzipanagiotou S, Spiliopoulou I, Zerva L, Petinaki E. Liakopoulos A, et al. Among authors: vourli s. Diagn Microbiol Infect Dis. 2014 Apr;78(4):487-90. doi: 10.1016/j.diagmicrobio.2013.12.017. Epub 2014 Jan 7. Diagn Microbiol Infect Dis. 2014. PMID: 24503505
56 results